Marshall Welcomes Cresco Labs

CHICAGO – October 4, 2021 — Cresco Labs Inc. (CSE:CL) (OTCQX:CRLBF) (“Cresco Labs” or “the Company”), a vertically integrated multistate operator and the number one U.S. wholesaler of branded cannabis products, today announced the opening of its new cultivation and processing facility located at 210 Oliver Dr. in Marshall, Michigan. Michigan Senator John Bizon, Michigan Representative Matt Hall, Marshall Mayor Joe Caron and other dignitaries joined Cresco Labs executives for brief remarks and a ribbon cutting ceremony.

Cresco Labs announced the facility will provide an additional 110 local employment opportunities throughout the Kalamazoo—Battle Creek—Coldwater—Jackson region, in addition to the 60 current employees. The open roles in cultivation and manufacturing offer an average starting wage of $15 per hour. The Company provides full-time employees with comprehensive benefits, including health, vision and dental insurance; 401(k); paid time off package inclusive of PTO, sick, holiday, volunteer and wellness days; and Cresco Labs equity. Hiring is already underway and interested candidates can visit boards.greenhouse.io/crescolabs to learn more and apply.

As the largest U.S. wholesaler, Cresco Labs is also pleased to announce the launch and availability of its flagship brand Cresco to Michigan patients and customers. Produced at the new facility, Cresco is the largest U.S. brand, according to marketing research firm BDS Analytics. The facility will also expand the accessibility of the Company’s 2021 Hash Bash Cup winning edibles brand, Mindy’s, as well as its Good News and High Supply brands.

“Michigan represents one of the largest opportunities in U.S. cannabis, surpassing mature markets like Oregon and Washington in sales this year, and at Cresco Labs we’re excited to be part of the state’s continued growth,” said Charlie Bachtell, CEO & Co-Founder at Cresco Labs. “Our new Marshall facility will have strong production capabilities delivering a widely-recognized portfolio of brands with products that Michigan patients and customers want most, in categories such as edibles and flower. We’re also proud to provide job opportunities for people living throughout the region to support a positive economic impact in local communities.”

Cresco Labs cultivates, manufactures and wholesale distributes branded products to dispensaries throughout the Michigan. For more information, visit www.crescolabs.com.

About Cresco Labs

Cresco Labs is one of the largest vertically integrated multistate cannabis operators in the United States, with a mission to normalize and professionalize the cannabis industry. Employing a consumer-packaged goods (“CPG”) approach, Cresco Labs is the largest wholesaler of branded cannabis products in the U.S. Its brands are designed to meet the needs of all consumer segments and comprised of some of the most recognized and trusted national brands including Cresco, High Supply, Mindy’s Edibles, Good News, Remedi, Wonder Wellness Co. and FloraCal Farms. Sunnyside, Cresco Labs’ national dispensary brand, is a wellness-focused retailer created to build trust, education and convenience for both existing and new cannabis consumers. Recognizing that the cannabis industry is poised to become one of the leading job creators in the country, Cresco Labs operates the industry’s largest Social Equity and Educational Development initiative, SEED, which was established to ensure that all members of society have the skills, knowledge and opportunity to work and own businesses in the cannabis industry. Learn more about Cresco Labs at www.crescolabs.com.

Forward Looking Statements

This press release contains “forward-looking information” within the meaning of applicable Canadian securities legislation and may also contain statements that may constitute “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Such forward-looking information and forward-looking statements are not representative of historical facts or information or current condition, but instead represent only the Company’s beliefs regarding future events, plans or objectives, many of which, by their nature, are inherently uncertain and outside of the Company’s control. Generally, such forward-looking information or forward-looking statements can be identified by the use of forward-looking terminology such as, ‘may,’ ‘will,’ ‘should,’ ‘could,’ ‘would,’ ‘expects,’ ‘plans,’ ‘anticipates,’ ‘believes,’ ‘estimates,’ ‘projects,’ ‘predicts,’ ‘potential’ or ‘continue’ or the negative of those forms or other comparable terms. The Company’s forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the Company’s actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements, including but not limited to those risks discussed under “Risk Factors” in the Company’s Annual Information Form for the year ended December 31, 2020 filed on March 26, 2021, and other documents filed by the Company with Canadian securities regulatory authorities; and other factors, many of which are beyond the control of the Company. Readers are cautioned that the foregoing list of factors is not exhaustive. Because of these uncertainties, you should not place undue reliance on the Company’s forward-looking statements. No assurances are given as to the future trading price or trading volumes of Cresco Labs’ shares, nor as to the Company’s financial performance in future financial periods. The Company does not intend to update any of these factors or to publicly announce the result of any revisions to any of the Company’s forward-looking statements contained herein, whether as a result of new information, any future event or otherwise. Except as otherwise indicated, this press release speaks as of the date hereof. The distribution of this press release does not imply that there has been no change in the affairs of the Company after the date hereof or create any duty or commitment to update or supplement any information provided in this press release or otherwise.

Contacts

Media:Jason Erkes, Cresco LabsChief Communications Officerpress@crescolabs.com

Investors:Jake Graves, Cresco Labs

Manager, Investor Relationsinvestors@crescolabs.com

For general Cresco Labs inquiries:312-929-0993info@crescolabs.com